Supplements Hub Logo

Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a health condition or take medications.

Molybdenum

Molybdenum

Molybdenum (Mo)

Also known as: Molybdenum Amino Acid Chelate, Sodium Molybdate, Ammonium Molybdate, Mo

Molybdenum is an essential trace mineral that serves as a cofactor for four important enzymes involved in amino acid metabolism and detoxification. Deficiency is extremely rare; most people get adequate amounts from diet.

Introduction

Molybdenum is an essential trace mineral required in extremely small amounts— the RDA is measured in micrograms (mcg) rather than milligrams. It serves as an essential component of the molybdenum cofactor (Moco), which is required for the activity of four human enzymes.

The body contains only about 9 milligrams of molybdenum, concentrated primarily in the liver, kidneys, and bones. It is efficiently absorbed from the intestine and excreted primarily through the urine.

Molybdenum is a critical component of four enzymes:

  1. Sulfite Oxidase: Converts sulfite to sulfate, a critical detoxification step. Without this enzyme, sulfite (toxic) accumulates while sulfate (needed for proteoglycan synthesis) is deficient.

  2. Xanthine Oxidase: Involved in purine metabolism, converting hypoxanthine to xanthine and xanthine to uric acid. Also plays a role in iron absorption and mobilization.

  3. Aldehyde Oxidase: Involved in metabolizing drugs and toxins, including the conversion of retinaldehyde (vitamin A aldehyde) to retinoic acid.

  4. Mitochondrial Amidoxime Reducing Component (mARC): Recently discovered enzyme involved in detoxification of N-hydroxylated compounds.

Through these enzymes, molybdenum is involved in:

  • Sulfite detoxification: Critical for people sensitive to sulfites in food
  • Purine metabolism: Affects uric acid production
  • Drug metabolism: Involved in processing certain medications
  • Iron mobilization: Xanthine oxidase helps release iron from liver stores

Molybdenum deficiency is exceptionally rare in humans. The only documented cases have been in patients receiving long-term total parenteral nutrition (TPN) without molybdenum supplementation, or in individuals with rare genetic defects in molybdenum cofactor synthesis.

Because deficiency is so rare and the mineral is abundant in common foods (legumes, grains, nuts), routine supplementation is unnecessary for virtually everyone. In fact, excessive molybdenum intake can interfere with copper absorption and cause adverse effects.

Molybdenum is sometimes included in trace mineral supplements and multivitamins at safe levels, but standalone high-dose molybdenum supplements are rarely indicated and should be used with caution.

Main Benefits

  • Essential cofactor for sulfite oxidase, which detoxifies sulfites by converting them to sulfates; critical for individuals with sulfite sensitivity.

  • Required for xanthine oxidase, involved in purine metabolism and iron mobilization from liver stores.

  • Cofactor for aldehyde oxidase, involved in drug metabolism and retinoic acid formation from vitamin A.

  • Supports the mARC enzyme system for detoxification of N-hydroxylated compounds and drug metabolism.

Mechanism of Action

Molybdenum functions exclusively as a component of the molybdenum cofactor (Moco), which is incorporated into four specific enzymes:

  1. Sulfite Oxidase Mechanism:
  • Catalyzes the conversion of sulfite (SO₃²⁻) to sulfate (SO₄²⁻)
  • Critical for detoxifying sulfites from food and metabolism
  • Sulfate produced is used for glycosaminoglycan synthesis (proteoglycans)
  • Without this enzyme, sulfite accumulates causing neurological damage
  1. Xanthine Oxidase Mechanism:
  • Catalyzes oxidation of hypoxanthine to xanthine to uric acid
  • Involved in purine catabolism
  • Also catalyzes iron release from ferritin in liver
  • May contribute to antioxidant defense through uric acid production
  1. Aldehyde Oxidase Mechanism:
  • Oxidizes aldehydes to carboxylic acids
  • Involved in metabolism of drugs and xenobiotics
  • Converts retinaldehyde to retinoic acid (active vitamin A)
  • Metabolizes various nitrogen-containing compounds
  1. mARC (Mitochondrial Amidoxime Reducing Component):
  • Reduces N-hydroxylated compounds
  • Involved in drug metabolism and detoxification
  • Recent discovery with evolving understanding of roles

Molybdenum Cofactor Synthesis: The body synthesizes Moco from molybdate (MoO₄²⁻) through a complex multi-step pathway. Genetic defects in this pathway cause molybdenum cofactor deficiency, a severe and often fatal condition presenting in infancy with seizures and developmental delay.

Natural Sources

Molybdenum is found in legumes (beans, lentils, peas), grains, nuts, and leafy vegetables. The molybdenum content of plants depends on soil concentration. Legumes are particularly rich sources. Animal products contain molybdenum based on the animal's diet.

Examples:

  • Legumes (beans, lentils, peas)

  • Whole grains

  • Nuts (almonds, cashews)

  • Leafy vegetables

  • Liver

  • Dairy products

Ease of Sourcing from Diet8/10

Widely available in common foods; legumes and grains are excellent sources; deficiency virtually impossible with normal diet.

Deficiency Symptoms

Molybdenum deficiency is extremely rare. Only documented in TPN patients without supplementation or genetic molybdenum cofactor deficiency. Symptoms include neurological damage from sulfite accumulation and impaired metabolism.

Common Symptoms:

  • Tachycardia

  • Tachypnea

  • Severe neurological abnormalities

  • Seizures (genetic cofactor deficiency)

  • Developmental delay

  • Brain atrophy

  • Ocular lens dislocation

Deficiency Prevalence1/10

Essentially nonexistent in free-living populations; only in TPN without supplementation or rare genetic disorders.

Impact of Deficiency9/10

Genetic molybdenum cofactor deficiency is fatal if untreated; acquired deficiency causes severe neurological impairment.

Recommended Daily Intake

RDA: Adults 45 mcg/day. UL: 2000 mcg (2 mg)/day for adults. Most people get 50-500 mcg/day from diet. Multivitamins typically provide 50-75 mcg. Standalone supplementation rarely needed.

Effectiveness for Specific Focuses

Detoxification Support6/10

Critical for sulfite detoxification; involved in drug metabolism; deficiency impairs detoxification but supplementation beyond RDA does not enhance detox in normal individuals.

Metabolic Health5/10

Required for purine metabolism and iron mobilization; essential metabolic cofactor but supplementation beyond RDA has limited benefit.

Safety Information

Potential Side Effects

  • Generally well-tolerated at RDA

  • Copper deficiency at high doses

  • Gout-like symptoms at excessive doses (high uric acid)

Contraindications

  • Copper deficiency (high molybdenum worsens)

  • Gout (may increase uric acid)

Overdose Information

Overdose Risk Level5/10

UL set at 2000 mcg/day; excess causes copper deficiency and gout-like symptoms; narrow therapeutic window relative to RDA.

Excessive intake causes copper deficiency and elevated uric acid, potentially triggering gout-like symptoms.

Documented Overdose Symptoms:

  • Copper deficiency

  • Anemia

  • Elevated uric acid

  • Joint pain

  • Gout-like symptoms

Toxicity Thresholds: UL of 2000 mcg/day based on copper deficiency risk. Toxicity rare but documented in high-exposure areas with molybdenum-rich soil.

Safe at RDA. Risk primarily from excessive supplementation or environmental exposure in molybdenum-rich areas.

Interactions

Important: This supplement may interact with medications. If you are taking prescription drugs, consult your doctor or pharmacist before use.

Drug Interactions:

  • Copper supplements (antagonistic interaction)

  • Allopurinol (affects xanthine oxidase)

Drug Interaction Risk4/10

Significant interaction with copper; high molybdenum causes copper deficiency.

Other Supplement Interactions:

  • Copper (critical antagonistic interaction)

  • Zinc (may interact)

Supplement Interaction Risk5/10

High molybdenum supplementation causes copper deficiency; avoid high-dose single-mineral supplements.

Do not exceed UL. Those with copper deficiency or gout should avoid supplementation. Rarely needed as standalone supplement.

Forms and Bioavailability

Molybdenum supplements typically as sodium molybdate or amino acid chelate. All forms well-absorbed. Usually included in trace mineral supplements rather than as standalone product.

Sodium Molybdate

Common supplemental form; well-absorbed; soluble salt form.

Relative Bioavailability8/10

Good absorption; widely used; stable form.

Common in supplements. Adequate for meeting needs.

Molybdenum Amino Acid Chelate

Chelated form; may have enhanced absorption.

Relative Bioavailability8/10

Good absorption through amino acid transporters.

Found in some premium multivitamins.

Warnings & Suitability

Consult DoctorMax Dosage Critical

Did You Know...?

  • Molybdenum was discovered in 1778 by Swedish chemist Carl Wilhelm Scheele, who initially confused it with lead and graphite due to its similar appearance.

  • The name "molybdenum" comes from the Greek word "molybdos" meaning lead, because the mineral molybdenite was originally thought to be a lead ore.

  • Genetic molybdenum cofactor deficiency is one of the few treatable causes of neonatal seizures—if diagnosed early, daily injections of cyclic pyranopterin monophosphate (cPMP) can normalize development.

  • Some areas in Armenia and China have naturally high molybdenum in soil and water, leading to a condition called "molybdenosis" in grazing animals, characterized by copper deficiency and anemia.

General Scientific Sources

Tags

mineraltrace-mineraldetoxificationsulfite

Content Verification

Content created with AI assistance and reviewed for accuracy. Sources are cited throughout the text.

Last Medical Review: 2/25/2026

Reviewed by: Prodata.cc

Found an issue?
Reklama (AdSense)